2001
DOI: 10.1016/s1074-5521(01)00043-6
|View full text |Cite
|
Sign up to set email alerts
|

Insights about the biosynthesis of the avermectin deoxysugar L-oleandrose through heterologous expression of Streptomyces avermitilis deoxysugar genes in Streptomyces lividans

Abstract: The plasmid-based reconstruction of the avr deoxysugar genes for expression in a heterologous system combined with biotransformation has led to new information about the mechanism of 2,6-deoxysugar biosynthesis. The structures of the di-demethyldeoxysugar avermectins accumulated indicate that in the oleandrose pathway the stereochemistry at C-3 is ultimately determined by the 3-O-methyltransferase and not by the 3-ketoreductase or a possible 3,5-epimerase. The AvrF protein is therefore a 5-epimerase and not a … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
38
0
2

Year Published

2001
2001
2014
2014

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 54 publications
(43 citation statements)
references
References 45 publications
3
38
0
2
Order By: Relevance
“…Epirubicin (compound 3b) production in the S. venezuelae system required the TDP-4-ketohexose reduction step which confers an equatorial C-4 hydroxyl group to TDP-4-keto-L-daunosamine, the glycosylation step attaching TDP-4-epi-L-daunosamine to ε-RHO, producing 4Ј-epi-rhodomycin D (compound 1b), and the postglycosylation steps leading to epirubicin (compound 3b). Glycosyltransferase/auxiliary protein pairs capable of converting ε-RHO to 4Ј-epi-rhodomycin D (compound 1b) efficiently were first screened using a TDP-4-epi-L-daunosamine biosynthetic gene cassette containing avrE, a gene encoding TDP-4-ketohexose reductase in the L-oleandrose biosynthetic pathway from S. avermitilis (46), in place of dmnV since it has already been reported that avrE can support 4Ј-epi-daunorubicin (compound 2b) production in S. peucetius (24). Four plasmids were constructed: pEDNS1, pEDNS2, pEDNS3, and pEDNS4 carrying aknS/aknT, dnmS/dnmQ, stfG/stfPII, and snogE/snogN, respectively (Table 2).…”
Section: Resultsmentioning
confidence: 99%
“…Epirubicin (compound 3b) production in the S. venezuelae system required the TDP-4-ketohexose reduction step which confers an equatorial C-4 hydroxyl group to TDP-4-keto-L-daunosamine, the glycosylation step attaching TDP-4-epi-L-daunosamine to ε-RHO, producing 4Ј-epi-rhodomycin D (compound 1b), and the postglycosylation steps leading to epirubicin (compound 3b). Glycosyltransferase/auxiliary protein pairs capable of converting ε-RHO to 4Ј-epi-rhodomycin D (compound 1b) efficiently were first screened using a TDP-4-epi-L-daunosamine biosynthetic gene cassette containing avrE, a gene encoding TDP-4-ketohexose reductase in the L-oleandrose biosynthetic pathway from S. avermitilis (46), in place of dmnV since it has already been reported that avrE can support 4Ј-epi-daunorubicin (compound 2b) production in S. peucetius (24). Four plasmids were constructed: pEDNS1, pEDNS2, pEDNS3, and pEDNS4 carrying aknS/aknT, dnmS/dnmQ, stfG/stfPII, and snogE/snogN, respectively (Table 2).…”
Section: Resultsmentioning
confidence: 99%
“…Interestingly, the producer organisms of these two compounds seem to have evolved two different pathways for synthesis and incorporation of the same sugar into the aglycon. In S. avermitilis, L-oleandrose is synthesized as a nucleotide-activated sugar that is transferred to the aglycon by a glycosyltransferase which incorporates two successive L-oleandrose moieties (12,27). In contrast, the oleandomycin producer S. antibioticus synthesizes the unmethylated derivative, L-olivose, which is transferred to the aglycon by the OleG2 glycosyltransferase and then converted into L-oleandrose by the OleY methyltransferase (Fig.…”
Section: Discussionmentioning
confidence: 99%
“…pQE60 (Qiagen) and pUWL201 (7) were used as expression vectors in E. coli and S. lividans, respectively. pWHM2109 is a plasmid containing all the L-oleandrose genes from the avermectin biosynthetic gene cluster in Streptomyces avermitilis (27). When antibiotic selection of transformants was needed, 100 g of ampicillin/ml, 25 g of thiostrepton/ml, or 25 g of apramycin/ml was used.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…The PCR product was cloned into ZERO-Blunt (Invitrogen), then a 0?7 kb NsiI-NsiI (one NsiI site is from the vector) fragment containing the ery-ORF5 gene was transferred into NsiI-cut pKOS146-83A (Table 1) to give plasmid pKOS146-101A. pKOS146-83A was made from pUC119 (Vieira & Messing, 1987), in which the HindIII-EcoRI polylinker was replaced by a HindIII-EcoRI fragment containing the actII-ORF4 gene and the divergent actI and actIII promoters from pWHM467 (Wohlert et al, 2001). Three fragments, the EcoRI-PacI fragment of pKOS146-101A, the HindIII-PacI fragment of pKOS146-88A (Table 1) and the EcoRI-HindIII fragment of pKOS146-87B (Table 1) were ligated together and packaged using a GigapackIII-plus (Stratagene) in vitro packaging kit.…”
mentioning
confidence: 99%